BLB&B Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$310K Sell
3,602
-307
-8% -$26.9K 0.01% 238
2026
Q1
$353K Sell
3,909
-371
-9% -$34K 0.01% 214
2025
Q4
$385K Sell
4,280
-148
-3% -$14K 0.02% 213
2025
Q3
$436K Buy
4,428
+53
+1% +$5.25K 0.02% 187
2025
Q2
$399K Sell
4,375
-100
-2% -$9.67K 0.02% 192
2025
Q1
$506K Sell
4,475
-125
-3% -$13.4K 0.03% 182
2024
Q4
$486K Sell
4,600
-300
-6% -$32.2K 0.02% 176
2024
Q3
$529K Buy
4,900
+100
+2% +$10.9K 0.03% 168
2024
Q2
$521K Sell
4,800
-300
-6% -$35.4K 0.03% 173
2024
Q1
$673K Sell
5,100
-15
-0.3% -$1.87K 0.04% 152
2023
Q4
$622K Sell
5,115
-103
-2% -$11.5K 0.04% 149
2023
Q3
$586K Sell
5,218
-35
-0.7% -$4.45K 0.04% 142
2023
Q2
$765K Sell
5,253
-34
-0.6% -$4.62K 0.05% 126
2023
Q1
$683K Sell
5,287
-163
-3% -$20.5K 0.05% 127
2022
Q4
$695K Sell
5,450
-575
-10% -$66.7K 0.05% 133
2022
Q3
$630K Sell
6,025
-64
-1% -$7.02K 0.05% 135
2022
Q2
$640K Sell
6,089
-81
-1% -$9.61K 0.05% 137
2022
Q1
$789K Sell
6,170
-237
-4% -$28.6K 0.05% 135
2021
Q4
$790K Sell
6,407
-903
-12% -$118K 0.05% 139
2021
Q3
$1.04M Sell
7,310
-372
-5% -$54.7K 0.07% 127
2021
Q2
$1.2M Sell
7,682
-249
-3% -$40.3K 0.09% 113
2021
Q1
$1.23M Sell
7,931
-1,404
-15% -$217K 0.1% 107
2020
Q4
$1.4M Sell
9,335
-618
-6% -$87.3K 0.11% 108
2020
Q3
$1.32M Sell
9,953
-293
-3% -$38.3K 0.13% 97
2020
Q2
$1.19M Sell
10,246
-716
-7% -$82.5K 0.13% 103
2020
Q1
$1.08M Sell
10,962
-52
-0.5% -$6.82K 0.14% 105
2019
Q4
$1.6M Sell
11,014
-61
-0.6% -$8.42K 0.17% 100
2019
Q3
$1.48M Sell
11,075
-149
-1% -$19.2K 0.17% 108
2019
Q2
$1.28M Sell
11,224
-232
-2% -$27.2K 0.15% 117
2019
Q1
$1.42M Sell
11,456
-623
-5% -$70.8K 0.17% 114
2018
Q4
$1.22M Sell
12,079
-327
-3% -$36.8K 0.17% 114
2018
Q3
$1.58M Sell
12,406
-711
-5% -$84.5K 0.2% 109
2018
Q2
$1.42M Sell
13,117
-211
-2% -$23K 0.19% 108
2018
Q1
$1.41M Sell
13,328
-592
-4% -$68.8K 0.19% 112
2017
Q4
$1.63M Sell
13,920
-240
-2% -$27.1K 0.23% 103
2017
Q3
$1.61M Buy
14,160
+128
+0.9% +$14.8K 0.25% 100
2017
Q2
$1.75M Sell
14,032
-128
-0.9% -$15.2K 0.29% 92
2017
Q1
$1.68M Sell
14,160
-258
-2% -$29.2K 0.29% 93
2016
Q4
$1.45M Buy
14,418
+52
+0.4% +$5.57K 0.25% 98
2016
Q3
$1.81M Sell
14,366
-325
-2% -$40.2K 0.33% 87
2016
Q2
$1.72M Sell
14,691
-154
-1% -$17.4K 0.32% 89
2016
Q1
$1.54M Hold
14,845
0.31% 89
2015
Q4
$1.48M Sell
14,845
-78
-0.5% -$7.63K 0.31% 87
2015
Q3
$1.36M Sell
14,923
-458
-3% -$45.9K 0.3% 92
2015
Q2
$1.63M Sell
15,381
-1,164
-7% -$129K 0.34% 87
2015
Q1
$1.89M Buy
16,545
+1,035
+7% +$118K 0.39% 77
2014
Q4
$1.71M Sell
15,510
-1,545
-9% -$163K 0.36% 76
2014
Q3
$1.67M Sell
17,055
-1,246
-7% -$123K 0.36% 74
2014
Q2
$1.84M Sell
18,301
-273
-1% -$26.6K 0.39% 68
2014
Q1
$1.71M Sell
18,574
-31
-0.2% -$2.86K 0.38% 68
2013
Q4
$1.68M Sell
18,605
-243
-1% -$21K 0.4% 69
2013
Q3
$1.5M Sell
18,848
-515
-3% -$40.5K 0.4% 67
2013
Q2
$1.41M Buy
+19,363
New +$1.45M 0.39% 71

Other funds holding ZBH

BLB&B Advisors's ZBH Position: Q2 2026 in Review

BLB&B Advisors reduced its Zimmer Biomet (ZBH) stake by 7.9% in Q2 2026, selling an estimated $26.9K and leaving 3,602 shares worth $310K. The position accounts for 0.01% of the portfolio, ranked #238.

BLB&B Advisors first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.89M in Q1 2015. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • BLB&B Advisors held 3,602 shares of Zimmer Biomet worth $310K as of Q2 2026.
  • BLB&B Advisors sold 307 Zimmer Biomet shares in Q2 2026, an estimated $26.9K.
  • Zimmer Biomet made up 0.01% of BLB&B Advisors's portfolio in Q2 2026, its #238 holding.
  • BLB&B Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • BLB&B Advisors's Zimmer Biomet position peaked at $1.89M in Q1 2015.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on BLB&B Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.